Search
for
Sort by
Research 31–60 of 876
- Deep Hair Phenomics: Implications in Endocrinology, Development, and Aging
- Update on Melasma—Part I: Pathogenesis
- Male Sex Hormones in Andrology Today
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- SÍNDROME DOS OVÁRIOS POLICÍSTICOS E MANIFESTAÇÕES DERMATOLÓGICAS: DO DIAGNÓSTICO À TERAPÊUTICA ESTÉTICA
- Imiquimod
- Polycystic Ovary Syndrome
- Hypothyroidism in polycystic ovarian syndrome: a comparative study of clinical characteristics, metabolic and hormonal parameters in euthyroid and hypothyroid polycystic ovarian syndrome women
- Spectrum and clinical burden of Unrecognized Dermatologic Diseases in hospitalized adults: A single-centre cross-sectional study
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Debatable Topics in PCOS Patients
- Hair loss
- Sindrome post-finasteride: tra mito e realtà
- 46,XY DSD due to impaired androgen production
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Alopecia and hirsutism*
- Diffuse hair loss associated with hyperprolactinaemia: report of three cases
- Advances in Tissue Bioengineering and Regenerative Aesthetic Medicine: Emerging Strategies for Tissue Restoration, Functional Recovery, and Personalized Healthcare
- Dermatological burden in polycystic ovary syndrome: Correlation of cutaneous manifestations with hormonal profile and quality of life in a hospital based cohort
- Assessment of the obese patient
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Management OF Patients with Polycystic Ovary Syndrom
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Madarosis
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- A Prospective Hospital-Based Study on Cutaneous Manifestations in Patients with Polycystic Ovarian Syndrome (PCOS)